Breast Carcinoma: Clinical Trials

13 trials for Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 recruiting, 2 active not recruiting, 2 terminated. 13 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 4, Recruiting 4, Active not recruiting 2, Terminated 2, Unknown 1
Phase 22Completed 1, Terminated 1

Follow Breast Carcinoma: new trials by email Literature Review of Breast Carcinoma trials Research Report on Breast Carcinoma

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Laser Therapy, Sham Intervention, Questionnaire Administration - Vaginal Atrophy, Breast Carcinoma
Phase 3RecruitingAlliance for Clinical Trials in Oncology2502026-04-212026-10-19
Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer
Regional Nodal Irradiation - Breast Carcinoma
Phase 3RecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences31422024-10-102025-01-03
ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
Endocrine therapy, Endocrine therapy combined with the local treatment of FES-negative lesions, Chemotherapy - Breast Carcinoma
Phase 3RecruitingInstitut Curie3002024-05-272026-04-17
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Immediate Lymphatic Reconstruction, Volumetric arm measurements, Lymphatic massage - Lymphedema, Lymphedema Arm
Phase 3RecruitingMemorial Sloan Kettering Cancer Center2852023-11-162026-11-10
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy
eftilagimod alpha, Paclitaxel, placebo - Breast Carcinoma
Phase 2 / Phase 3TerminatedImmutep S.A.S.722023-05-222026-07-30
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
Denosumab, Placebo, Quality-of-Life Assessment - BRCA1 Mutation, Breast Cancer
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology3002023-02-142026-10-05
Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy
Best Practice, Wound Dressing Material, Quality-of-Life Assessment - Breast Carcinoma
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology2162022-07-262026-09-23
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Cimetidine, Dexamethasone, Diphenhydramine - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8
Phase 2 / Phase 3CompletedOhio State University Comprehensive Cancer Center1302021-10-072025-08-20
Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer
skin-oriented spa care, Pentoxifylline, Tocopherol acetate - Breast Carcinoma, Fibrosis
Phase 3UnknownInstitut de Cancérologie de Lorraine1422018-12-012018-08-08
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer
Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride - Breast Carcinoma
Phase 3CompletedUniversity of Rochester NCORP Research Base13632018-04-192025-09-25
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
Indocyanine green, Technetium99, Optonuclear probe - Breast Carcinoma, Head and Neck Cancer
Phase 3CompletedInstitut de Cancérologie de Lorraine7442017-11-292026-09-01
Oxybutynin Chloride in Managing Hot Flashes
Oxybutynin Chloride, Placebo, Quality-of-Life Assessment - Breast Carcinoma, Ductal Breast Carcinoma In Situ
Phase 3CompletedAcademic and Community Cancer Research United1502016-12-092020-01-18
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
Bevacizumab, Carboplatin, Paclitaxel - Breast Carcinoma, Recurrent Breast Carcinoma
Phase 3TerminatedNational Cancer Institute (NCI)962007-11-012026-06-23

Narrower conditions

Breast Neoplasms (13)  ·  Breast Carcinoma In Situ (2)  ·  Neoplasms (2)  ·  Anus Neoplasms (1)  ·  Breast Diseases (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Carcinoma, Squamous Cell (1)  ·  Endometrial Neoplasms (1)  ·  Fibrosis (1)  ·  Head and Neck Neoplasms (1)  ·  Hot Flashes (1)  ·  Lymphedema (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Neoplasms by Site (13)  ·  Skin Diseases (13)  ·  Skin and Connective Tissue Diseases (13)  ·  Breast Diseases (12)  ·  Neoplasms (11)  ·  Carcinoma (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Carcinoma in Situ (2)  ·  Pathologic Processes (2)  ·  Adenocarcinoma (1)  ·  Adnexal Diseases (1)  ·  Anus Diseases (1)  ·  Colorectal Neoplasms (1)

Interventions

Paclitaxel (3)  ·  Calcium Dobesilate (2)  ·  Dexamethasone (2)  ·  auricularum (2)  ·  dexamethasone 21-phosphate (2)  ·  dexamethasone acetate (2)  ·  Bandages (1)  ·  Bevacizumab (1)  ·  Carboplatin (1)  ·  Cimetidine (1)  ·  Denosumab (1)  ·  Diphenhydramine (1)  ·  Drug Therapy (1)  ·  Famotidine (1)  ·  Indocyanine Green (1)

Sponsors

Alliance for Clinical Trials in Oncology (3)  ·  Institut de Cancérologie de Lorraine (2)  ·  Academic and Community Cancer Research United (1)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Immutep S.A.S. (1)  ·  Institut Curie (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  University of Rochester NCORP Research Base (1)

Countries

United States (9)  ·  France (3)  ·  Belgium (1)  ·  China (1)  ·  Georgia (1)  ·  Moldova (1)  ·  Spain (1)

Top investigators

Charles Loprinzi (1)  ·  Ingrid Mayer (1)  ·  Judy E. Garber, MD, MPH (1)  ·  Kimberly Corbin, MD (1)  ·  Luke Peppone (1)  ·  Maryam Lustberg, MD, MPH (1)  ·  Michael J Berger, Pharm.D. (1)  ·  Michelle Coriddi, MD (1)

Results publications

PMID 38967884

NIH funding

UG1CA189823 (3), 2016 (1), 2017 (1), 2023 (1), P30CA015083 (1), R01CA200579 (1), U10CA023318 (1), U10CA180794 (1), UG1CA189961 (1)